APA

Zhou J., Wu Z., Wong G., Pectasides E., Nagaraja A., Stachler M., Zhang H., Chen T., Zhang H., Liu J. B., Xu X., Sicinska E., Sanchez-Vega F., Rustgi A. K., Diehl J. A., Wong K. & Bass A. J. (20181109). CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. : Nature communications.

Chicago

Zhou Jin, Wu Zhong, Wong Gabrielle, Pectasides Eirini, Nagaraja Ankur, Stachler Matthew, Zhang Haikuo, Chen Ting, Zhang Haisheng, Liu Jie Bin, Xu Xinsen, Sicinska Ewa, Sanchez-Vega Francisco, Rustgi Anil K, Diehl J Alan, Wong Kwok-Kin and Bass Adam J. 20181109. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. : Nature communications.

Harvard

Zhou J., Wu Z., Wong G., Pectasides E., Nagaraja A., Stachler M., Zhang H., Chen T., Zhang H., Liu J. B., Xu X., Sicinska E., Sanchez-Vega F., Rustgi A. K., Diehl J. A., Wong K. and Bass A. J. (20181109). CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. : Nature communications.

MLA

Zhou Jin, Wu Zhong, Wong Gabrielle, Pectasides Eirini, Nagaraja Ankur, Stachler Matthew, Zhang Haikuo, Chen Ting, Zhang Haisheng, Liu Jie Bin, Xu Xinsen, Sicinska Ewa, Sanchez-Vega Francisco, Rustgi Anil K, Diehl J Alan, Wong Kwok-Kin and Bass Adam J. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. : Nature communications. 20181109.